Aurora a Kinase Inhibition Destabilizes PAX3-FOXO1 and MYCN and Synergizes With Navitoclax to Induce Rhabdomyosarcoma Cell Death

Cancer Research - United States
doi 10.1158/0008-5472.can-19-1479
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Sphingosine Induces Apoptosis and Down-Regulation of MYCN in PAX3–FOXO1-positive Alveolar Rhabdomyosarcoma Cells Irrespective of TP53 Mutation

Anticancer Research
MedicineCancer ResearchOncology
2018English

Chloroquine Synergizes With FTS to Enhance Cell Growth Inhibition and Cell Death

Oncotarget
Oncology
2013English

Selinexor Synergizes With Dexamethasone to Repress mTORC1 Signaling and Induce Multiple Myeloma Cell Death

Oncotarget
Oncology
2018English

Alveolar Rhabdomyosarcoma–associated PAX3-FOXO1 Promotes Tumorigenesis via Hippo Pathway Suppression

Journal of Clinical Investigation
Medicine
2013English

Alveolar Rhabdomyosarcoma – The Molecular Drivers of PAX3/7-FOXO1-induced Tumorigenesis

Skeletal Muscle
OrthopedicsSports MedicineCell BiologyMolecular Biology
2012English

The PI3K Inhibitor Copanlisib Synergizes With Sorafenib to Induce Cell Death in Hepatocellular Carcinoma

Cell Death Discovery
Cancer ResearchMolecular NeuroscienceImmunologyCell BiologyCellular
2019English

The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

LMO1 Synergizes With MYCN to Promote Neuroblastoma Initiation and Metastasis

Cancer Cell
Cancer ResearchOncologyCell Biology
2017English

Aurora B Kinase Is a Potent and Selective Target in MYCN-driven Neuroblastoma

Oncotarget
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy